BCL2 and inflammatory bowel disease: Our finding on even lower levels in IBD patients, combined with findings on decreased concentrations of cytochrome c and caspase 9, seems to be strong evidence of apoptosis resistance of LE-PBMCs despite, also decreased, concentrations of Bcl-2.